OncLiveDr. Balmanoukian on Immunotherapy Advancements in GU CancersOncLiveAni Balmanoukian, MD, director of Thoracic Oncology, associate director of the Phase I Immune-Oncology Program, The Angeles Clinic and Research Institute, discusses immunotherapy… Continue reading
Mitochondrial Disease NewsPotential Gene Therapy May Improve Survival in MNGIE Patients, Mouse Study SuggestsMitochondrial Disease NewsAs a possible treatment alternative, a research team presented a potential TYMP gene therapy strategy for MNGIE. Led … Continue reading
Phys.Org |
Drug-producing bacteria possible with synthetic biology breakthrough
Science Daily Led by the Warwick Integrative Synthetic Biology Centre at Warwick’s School of Engineering and the Faculty of Health and Medical Sciences at the University of Surrey, new research has discovered how to dynamically manage the allocation of essential … Drug-producing bacteria possible with synthetic biology breakthroughPhys.Org Synthetic Biology Market: By Tool; By Technology; By Application & By Geography – Forecast (2017-2023 …satPRnews (press release) |
|
Sorrento’s liver artery-infused CAR–T cells showed positive effect in early-stage study
Seeking Alpha Results from three heavily pretreated patients with CEA-positive liver metastases in a Phase 1b clinical trial who received Sorrento Therapeutics’ (SRNE -1.4%) autologous anti-CEA CAR–T cells via hepatic artery infusion showed a treatment effect … Sorrento (SRNE) Says Anti-CEA CAR-T Cell Therapy for Liver …StreetInsider.com Sorrento Therapeutics Autologous Anti-CEA CAR-T Cell Therapy for …GlobeNewswire (press release) |